A股異動 | 志特新材(300986.SZ)漲10% 推股權激勵 要求未來三年營收之和最低73.94億
格隆匯5月10日丨志特新材(300986.SZ)現漲10%,報33.3元,暫成交6637萬元已超昨日全天成交額,總市值39億元。公司昨晚公吿,擬推2022年限制性股票激勵計劃,授予價為16.8元/股。考核方面,志特新材要求公司2022年至2024年營業收入之和觸發值為73.94億元,目標值為92.43億元。此舉公司利益和激勵對象個人利益結合在一起,使各方共同關注公司的長遠發展,提升公司的核心競爭力。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.